Latest filing published 27 Dec 2011 for ALSERES PHARMACEUTICALS INC /DE.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Robert L. Gipson: trading record in brief
Filings by Robert L. Gipson span 2 companies, the busiest being Alseres Pharmaceuticals Inc /DE and Advance Nanotech, Inc. We count 10 filings; the first trade dates from 11 June 2007 and the latest from 27 December 2011.
No open-market sale appears; the market trades are 2 purchases worth €1.5M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 1 option exercise.
The latest filing, published on 27 December 2011, reports a transaction in Alseres Pharmaceuticals Inc /DE. The most recent open-market purchase was published on 23 April 2009, 6,408 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Robert L. Gipson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,331,034 shares0common stockSEC:0001041885-11-000098:0
- 2,331,034 shares0common stockSEC:0001041885-11-000096:0
- 2,331,034 shares@ US$2.50common stockSEC:0001041885-11-000091:0
- 60,000 shares@ US$0.01COMMON STOCKSEC:0001041885-11-000084:0
- 4,600,000 shares0COMMON STOCKSEC:0001041885-11-000083:0
- 270,000 shares@ US$0.03COMMON STOCKSEC:0001041885-11-000008:0
- 543,478 shares@ US$1.84Common StockSEC:0001041885-09-000080:0Canonical exit: 18 Feb 2009 (T+90)
- 1,456,522 shares@ US$0.687Common StockSEC:0001041885-09-000080:1Canonical exit: 9 Apr 2009 (T+90)
8 of 8 declarations